Matches in Nanopublications for { ?s ?p "[Crossbreeding of the hSOD1G93A transgenic mouse model of ALS with chat-GluR2 mice led to marked delay of disease onset (19.5%), mortality (14.3%) and the pathological hallmarks such as release of cytochrome c from mitochondria, induction of cox2 and astrogliosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- assertion description "[Crossbreeding of the hSOD1G93A transgenic mouse model of ALS with chat-GluR2 mice led to marked delay of disease onset (19.5%), mortality (14.3%) and the pathological hallmarks such as release of cytochrome c from mitochondria, induction of cox2 and astrogliosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Crossbreeding of the hSOD1G93A transgenic mouse model of ALS with chat-GluR2 mice led to marked delay of disease onset (19.5%), mortality (14.3%) and the pathological hallmarks such as release of cytochrome c from mitochondria, induction of cox2 and astrogliosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Crossbreeding of the hSOD1G93A transgenic mouse model of ALS with chat-GluR2 mice led to marked delay of disease onset (19.5%), mortality (14.3%) and the pathological hallmarks such as release of cytochrome c from mitochondria, induction of cox2 and astrogliosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP454713.RAhlQJq9q3vUSbM0MFRQcIYVDgC3Xx7Zn32LxIVQDyMoc130_assertion description "[Crossbreeding of the hSOD1G93A transgenic mouse model of ALS with chat-GluR2 mice led to marked delay of disease onset (19.5%), mortality (14.3%) and the pathological hallmarks such as release of cytochrome c from mitochondria, induction of cox2 and astrogliosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454713.RAhlQJq9q3vUSbM0MFRQcIYVDgC3Xx7Zn32LxIVQDyMoc130_provenance.
- NP454716.RAtE-dNdBfmTL9nHILWT1dT86d2YM5fQ8CMRDfD1i9UD4130_assertion description "[Crossbreeding of the hSOD1G93A transgenic mouse model of ALS with chat-GluR2 mice led to marked delay of disease onset (19.5%), mortality (14.3%) and the pathological hallmarks such as release of cytochrome c from mitochondria, induction of cox2 and astrogliosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454716.RAtE-dNdBfmTL9nHILWT1dT86d2YM5fQ8CMRDfD1i9UD4130_provenance.
- NP435542.RA0LfvAWm13qxUQtO2cK4ftt0Y0PN1caNuwm4QTcb0ksU130_assertion description "[Crossbreeding of the hSOD1G93A transgenic mouse model of ALS with chat-GluR2 mice led to marked delay of disease onset (19.5%), mortality (14.3%) and the pathological hallmarks such as release of cytochrome c from mitochondria, induction of cox2 and astrogliosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435542.RA0LfvAWm13qxUQtO2cK4ftt0Y0PN1caNuwm4QTcb0ksU130_provenance.
- NP433775.RAJUxBnfbiK9fSxneSa3SYmLFN7uLPFbkUaV2N4qbg5Go130_assertion description "[Crossbreeding of the hSOD1G93A transgenic mouse model of ALS with chat-GluR2 mice led to marked delay of disease onset (19.5%), mortality (14.3%) and the pathological hallmarks such as release of cytochrome c from mitochondria, induction of cox2 and astrogliosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433775.RAJUxBnfbiK9fSxneSa3SYmLFN7uLPFbkUaV2N4qbg5Go130_provenance.
- NP572888.RA1mSk-IzZtWTuqSHLRe6ZamHvXHolmDJrkXz7JTDkxeM130_assertion description "[Crossbreeding of the hSOD1G93A transgenic mouse model of ALS with chat-GluR2 mice led to marked delay of disease onset (19.5%), mortality (14.3%) and the pathological hallmarks such as release of cytochrome c from mitochondria, induction of cox2 and astrogliosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572888.RA1mSk-IzZtWTuqSHLRe6ZamHvXHolmDJrkXz7JTDkxeM130_provenance.
- NP454714.RAMap_FS6qVEEMHZWECqrczuoGiudVKxL7QFwsFIjgDAQ130_assertion description "[Crossbreeding of the hSOD1G93A transgenic mouse model of ALS with chat-GluR2 mice led to marked delay of disease onset (19.5%), mortality (14.3%) and the pathological hallmarks such as release of cytochrome c from mitochondria, induction of cox2 and astrogliosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454714.RAMap_FS6qVEEMHZWECqrczuoGiudVKxL7QFwsFIjgDAQ130_provenance.
- NP656741.RA1ohInIvNgoabjVtUMqjDp2U7JCq156LSPis8FiSHVKY130_assertion description "[Crossbreeding of the hSOD1G93A transgenic mouse model of ALS with chat-GluR2 mice led to marked delay of disease onset (19.5%), mortality (14.3%) and the pathological hallmarks such as release of cytochrome c from mitochondria, induction of cox2 and astrogliosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656741.RA1ohInIvNgoabjVtUMqjDp2U7JCq156LSPis8FiSHVKY130_provenance.
- NP454715.RA57CQ7CQym4w3caEZ7gRQOn2fCU12Mr4EMMFc_FTEVk0130_assertion description "[Crossbreeding of the hSOD1G93A transgenic mouse model of ALS with chat-GluR2 mice led to marked delay of disease onset (19.5%), mortality (14.3%) and the pathological hallmarks such as release of cytochrome c from mitochondria, induction of cox2 and astrogliosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454715.RA57CQ7CQym4w3caEZ7gRQOn2fCU12Mr4EMMFc_FTEVk0130_provenance.